ScholarLens Back to search
2017•The American Journal of CardiologyRequires access

Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial

Cheol Hyun Lee, Jong‐Young Lee, Gyung‐Min Park, Seung‐Whan Lee, Hyun‐Sook Kim, Young Jin Choi, Chang‐Wook Nam, Jang Hyun Cho, Won-Yong Shin, Jae Bin Seo, Si Wan Choi, Jae‐Hwan Lee, Pil‐Ki Min, Sung‐Ho Her, Pil Hyung Lee, Jung‐Min Ahn, Duk‐Woo Park, Soo‐Jin Kang, Young‐Hak Kim, Cheol Whan Lee, Seong‐Wook Park, Seung‐Jung Park

Open publisher page 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cilostazol, Clopidogrel, Aspirin, Medicine, Placebo, Cardiology, Antiplatelet drug, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial — Research Paper | ScholarLens